US 11,912,681 B2
Crystalline and salt forms of PPAR agonist compounds
Bharat Lagu, Acton, MA (US); and Scott Trzaska, Raritan, NJ (US)
Assigned to Mitobridge, Inc., Cambridge, MA (US)
Filed by Mitobridge, Inc., Cambridge, MA (US)
Filed on Dec. 16, 2022, as Appl. No. 18/082,847.
Application 18/082,847 is a continuation of application No. 17/179,604, filed on Feb. 19, 2021, granted, now 11,530,192.
Application 17/179,604 is a continuation of application No. 16/334,746, granted, now 10,927,094, issued on Feb. 23, 2021, previously published as PCT/US2017/055403, filed on Oct. 5, 2017.
Claims priority of provisional application 62/404,474, filed on Oct. 5, 2016.
Prior Publication US 2023/0257360 A1, Aug. 17, 2023
Int. Cl. C07D 401/04 (2006.01); C07D 233/60 (2006.01); C07D 233/64 (2006.01)
CPC C07D 401/04 (2013.01) [C07D 233/60 (2013.01); C07D 233/64 (2013.01); C07B 2200/13 (2013.01)] 9 Claims
 
1. A compound of Formula (II):

OG Complex Work Unit Chemistry
in the form of a meglumine salt or a hydrate of the meglumine salt.